img

Global Eosinophilic Disease Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Eosinophilic Disease Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Eosinophils are the variety of white infection, allergy blood cells and one of the major immune system components helps in combating various and inflammatory diseases. Eosinophils develops and mature in the bone marrow and represent upto 6% of bone marrow. If the threshold of 1500 cells/μl crosses called as eosinophil-driven diseases, which causes severe inflammatory diseases and organ damage.
Eosinophilic Disease report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Eosinophilic Disease market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Eosinophilic Esophagitis and Eosinophilic Granulomatosis with Polyangiitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Eosinophilic Disease industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Eosinophilic Disease key manufacturers include Takeda Pharmaceutical Company Limited, Ellodi Pharmaceuticals, Bristol-Myers Squibb Company, AstraZeneca, GSK plc, Regeneron Pharmaceuticals Inc, Allakos Inc, Arena Pharmaceuticals Ltd and Revolo Biotherapeutics, etc. Takeda Pharmaceutical Company Limited, Ellodi Pharmaceuticals, Bristol-Myers Squibb Company are top 3 players and held % sales share in total in 2022.
Eosinophilic Disease can be divided into Corticosteroids, Monoclonal Antibodies, Anti-cytokine Drug and Cytotoxic Drug, etc. Corticosteroids is the mainstream product in the market, accounting for % sales share globally in 2022.
Eosinophilic Disease is widely used in various fields, such as Eosinophilic Esophagitis, Eosinophilic Granulomatosis with Polyangiitis, Hyper-eosinophilic Syndrome and Nasal Polyposis, etc. Eosinophilic Esophagitis provides greatest supports to the Eosinophilic Disease industry development. In 2022, global % sales of Eosinophilic Disease went into Eosinophilic Esophagitis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Eosinophilic Disease market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Takeda Pharmaceutical Company Limited
Ellodi Pharmaceuticals
Bristol-Myers Squibb Company
AstraZeneca
GSK plc
Regeneron Pharmaceuticals Inc
Allakos Inc
Arena Pharmaceuticals Ltd
Revolo Biotherapeutics
DBV Technologies
Cipla Inc
Sun Pharmaceutical Industries Ltd
Sanofi
Segment by Type
Corticosteroids
Monoclonal Antibodies
Anti-cytokine Drug
Cytotoxic Drug

Segment by Application


Eosinophilic Esophagitis
Eosinophilic Granulomatosis with Polyangiitis
Hyper-eosinophilic Syndrome
Nasal Polyposis
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Eosinophilic Disease market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Eosinophilic Disease, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Eosinophilic Disease industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Eosinophilic Disease in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Eosinophilic Disease introduction, etc. Eosinophilic Disease Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Eosinophilic Disease market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Eosinophilic Disease Market Overview
1.1 Eosinophilic Disease Product Overview
1.2 Eosinophilic Disease Market Segment by Type
1.2.1 Corticosteroids
1.2.2 Monoclonal Antibodies
1.2.3 Anti-cytokine Drug
1.2.4 Cytotoxic Drug
1.3 Global Eosinophilic Disease Market Size by Type
1.3.1 Global Eosinophilic Disease Market Size Overview by Type (2024-2034)
1.3.2 Global Eosinophilic Disease Historic Market Size Review by Type (2024-2024)
1.3.3 Global Eosinophilic Disease Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Eosinophilic Disease Sales Breakdown by Type (2024-2024)
1.4.2 Europe Eosinophilic Disease Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Eosinophilic Disease Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Eosinophilic Disease Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Eosinophilic Disease Sales Breakdown by Type (2024-2024)
2 Global Eosinophilic Disease Market Competition by Company
2.1 Global Top Players by Eosinophilic Disease Sales (2024-2024)
2.2 Global Top Players by Eosinophilic Disease Revenue (2024-2024)
2.3 Global Top Players by Eosinophilic Disease Price (2024-2024)
2.4 Global Top Manufacturers Eosinophilic Disease Manufacturing Base Distribution, Sales Area, Product Type
2.5 Eosinophilic Disease Market Competitive Situation and Trends
2.5.1 Eosinophilic Disease Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Eosinophilic Disease Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eosinophilic Disease as of 2022)
2.7 Date of Key Manufacturers Enter into Eosinophilic Disease Market
2.8 Key Manufacturers Eosinophilic Disease Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Eosinophilic Disease Status and Outlook by Region
3.1 Global Eosinophilic Disease Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Eosinophilic Disease Historic Market Size by Region
3.2.1 Global Eosinophilic Disease Sales in Volume by Region (2024-2024)
3.2.2 Global Eosinophilic Disease Sales in Value by Region (2024-2024)
3.2.3 Global Eosinophilic Disease Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Eosinophilic Disease Forecasted Market Size by Region
3.3.1 Global Eosinophilic Disease Sales in Volume by Region (2024-2034)
3.3.2 Global Eosinophilic Disease Sales in Value by Region (2024-2034)
3.3.3 Global Eosinophilic Disease Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Eosinophilic Disease by Application
4.1 Eosinophilic Disease Market Segment by Application
4.1.1 Eosinophilic Esophagitis
4.1.2 Eosinophilic Granulomatosis with Polyangiitis
4.1.3 Hyper-eosinophilic Syndrome
4.1.4 Nasal Polyposis
4.1.5 Other
4.2 Global Eosinophilic Disease Market Size by Application
4.2.1 Global Eosinophilic Disease Market Size Overview by Application (2024-2034)
4.2.2 Global Eosinophilic Disease Historic Market Size Review by Application (2024-2024)
4.2.3 Global Eosinophilic Disease Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Eosinophilic Disease Sales Breakdown by Application (2024-2024)
4.3.2 Europe Eosinophilic Disease Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Eosinophilic Disease Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Eosinophilic Disease Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Eosinophilic Disease Sales Breakdown by Application (2024-2024)
5 North America Eosinophilic Disease by Country
5.1 North America Eosinophilic Disease Historic Market Size by Country
5.1.1 North America Eosinophilic Disease Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Eosinophilic Disease Sales in Volume by Country (2024-2024)
5.1.3 North America Eosinophilic Disease Sales in Value by Country (2024-2024)
5.2 North America Eosinophilic Disease Forecasted Market Size by Country
5.2.1 North America Eosinophilic Disease Sales in Volume by Country (2024-2034)
5.2.2 North America Eosinophilic Disease Sales in Value by Country (2024-2034)
6 Europe Eosinophilic Disease by Country
6.1 Europe Eosinophilic Disease Historic Market Size by Country
6.1.1 Europe Eosinophilic Disease Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Eosinophilic Disease Sales in Volume by Country (2024-2024)
6.1.3 Europe Eosinophilic Disease Sales in Value by Country (2024-2024)
6.2 Europe Eosinophilic Disease Forecasted Market Size by Country
6.2.1 Europe Eosinophilic Disease Sales in Volume by Country (2024-2034)
6.2.2 Europe Eosinophilic Disease Sales in Value by Country (2024-2034)
7 Asia-Pacific Eosinophilic Disease by Region
7.1 Asia-Pacific Eosinophilic Disease Historic Market Size by Region
7.1.1 Asia-Pacific Eosinophilic Disease Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Eosinophilic Disease Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Eosinophilic Disease Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Eosinophilic Disease Forecasted Market Size by Region
7.2.1 Asia-Pacific Eosinophilic Disease Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Eosinophilic Disease Sales in Value by Region (2024-2034)
8 Latin America Eosinophilic Disease by Country
8.1 Latin America Eosinophilic Disease Historic Market Size by Country
8.1.1 Latin America Eosinophilic Disease Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Eosinophilic Disease Sales in Volume by Country (2024-2024)
8.1.3 Latin America Eosinophilic Disease Sales in Value by Country (2024-2024)
8.2 Latin America Eosinophilic Disease Forecasted Market Size by Country
8.2.1 Latin America Eosinophilic Disease Sales in Volume by Country (2024-2034)
8.2.2 Latin America Eosinophilic Disease Sales in Value by Country (2024-2034)
9 Middle East and Africa Eosinophilic Disease by Country
9.1 Middle East and Africa Eosinophilic Disease Historic Market Size by Country
9.1.1 Middle East and Africa Eosinophilic Disease Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Eosinophilic Disease Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Eosinophilic Disease Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Eosinophilic Disease Forecasted Market Size by Country
9.2.1 Middle East and Africa Eosinophilic Disease Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Eosinophilic Disease Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Takeda Pharmaceutical Company Limited
10.1.1 Takeda Pharmaceutical Company Limited Company Information
10.1.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview
10.1.3 Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Takeda Pharmaceutical Company Limited Eosinophilic Disease Products Offered
10.1.5 Takeda Pharmaceutical Company Limited Recent Development
10.2 Ellodi Pharmaceuticals
10.2.1 Ellodi Pharmaceuticals Company Information
10.2.2 Ellodi Pharmaceuticals Introduction and Business Overview
10.2.3 Ellodi Pharmaceuticals Eosinophilic Disease Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Ellodi Pharmaceuticals Eosinophilic Disease Products Offered
10.2.5 Ellodi Pharmaceuticals Recent Development
10.3 Bristol-Myers Squibb Company
10.3.1 Bristol-Myers Squibb Company Company Information
10.3.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.3.3 Bristol-Myers Squibb Company Eosinophilic Disease Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Bristol-Myers Squibb Company Eosinophilic Disease Products Offered
10.3.5 Bristol-Myers Squibb Company Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information
10.4.2 AstraZeneca Introduction and Business Overview
10.4.3 AstraZeneca Eosinophilic Disease Sales, Revenue and Gross Margin (2024-2024)
10.4.4 AstraZeneca Eosinophilic Disease Products Offered
10.4.5 AstraZeneca Recent Development
10.5 GSK plc
10.5.1 GSK plc Company Information
10.5.2 GSK plc Introduction and Business Overview
10.5.3 GSK plc Eosinophilic Disease Sales, Revenue and Gross Margin (2024-2024)
10.5.4 GSK plc Eosinophilic Disease Products Offered
10.5.5 GSK plc Recent Development
10.6 Regeneron Pharmaceuticals Inc
10.6.1 Regeneron Pharmaceuticals Inc Company Information
10.6.2 Regeneron Pharmaceuticals Inc Introduction and Business Overview
10.6.3 Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Regeneron Pharmaceuticals Inc Eosinophilic Disease Products Offered
10.6.5 Regeneron Pharmaceuticals Inc Recent Development
10.7 Allakos Inc
10.7.1 Allakos Inc Company Information
10.7.2 Allakos Inc Introduction and Business Overview
10.7.3 Allakos Inc Eosinophilic Disease Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Allakos Inc Eosinophilic Disease Products Offered
10.7.5 Allakos Inc Recent Development
10.8 Arena Pharmaceuticals Ltd
10.8.1 Arena Pharmaceuticals Ltd Company Information
10.8.2 Arena Pharmaceuticals Ltd Introduction and Business Overview
10.8.3 Arena Pharmaceuticals Ltd Eosinophilic Disease Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Arena Pharmaceuticals Ltd Eosinophilic Disease Products Offered
10.8.5 Arena Pharmaceuticals Ltd Recent Development
10.9 Revolo Biotherapeutics
10.9.1 Revolo Biotherapeutics Company Information
10.9.2 Revolo Biotherapeutics Introduction and Business Overview
10.9.3 Revolo Biotherapeutics Eosinophilic Disease Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Revolo Biotherapeutics Eosinophilic Disease Products Offered
10.9.5 Revolo Biotherapeutics Recent Development
10.10 DBV Technologies
10.10.1 DBV Technologies Company Information
10.10.2 DBV Technologies Introduction and Business Overview
10.10.3 DBV Technologies Eosinophilic Disease Sales, Revenue and Gross Margin (2024-2024)
10.10.4 DBV Technologies Eosinophilic Disease Products Offered
10.10.5 DBV Technologies Recent Development
10.11 Cipla Inc
10.11.1 Cipla Inc Company Information
10.11.2 Cipla Inc Introduction and Business Overview
10.11.3 Cipla Inc Eosinophilic Disease Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Cipla Inc Eosinophilic Disease Products Offered
10.11.5 Cipla Inc Recent Development
10.12 Sun Pharmaceutical Industries Ltd
10.12.1 Sun Pharmaceutical Industries Ltd Company Information
10.12.2 Sun Pharmaceutical Industries Ltd Introduction and Business Overview
10.12.3 Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Sun Pharmaceutical Industries Ltd Eosinophilic Disease Products Offered
10.12.5 Sun Pharmaceutical Industries Ltd Recent Development
10.13 Sanofi
10.13.1 Sanofi Company Information
10.13.2 Sanofi Introduction and Business Overview
10.13.3 Sanofi Eosinophilic Disease Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Sanofi Eosinophilic Disease Products Offered
10.13.5 Sanofi Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Eosinophilic Disease Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Eosinophilic Disease Industrial Chain Analysis
11.4 Eosinophilic Disease Market Dynamics
11.4.1 Eosinophilic Disease Industry Trends
11.4.2 Eosinophilic Disease Market Drivers
11.4.3 Eosinophilic Disease Market Challenges
11.4.4 Eosinophilic Disease Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Eosinophilic Disease Distributors
12.3 Eosinophilic Disease Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Corticosteroids
Table 2. Major Company of Monoclonal Antibodies
Table 3. Major Company of Anti-cytokine Drug
Table 4. Major Company of Cytotoxic Drug
Table 5. Global Eosinophilic Disease Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Eosinophilic Disease Sales by Type (2024-2024) & (K Units)
Table 7. Global Eosinophilic Disease Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Eosinophilic Disease Sales by Type (2024-2024) & (US& Million)
Table 9. Global Eosinophilic Disease Market Share in Value by Type (2024-2024)
Table 10. Global Eosinophilic Disease Price by Type (2024-2024) & (US$/Unit)
Table 11. Global Eosinophilic Disease Sales by Type (2024-2034) & (K Units)
Table 12. Global Eosinophilic Disease Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Eosinophilic Disease Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Eosinophilic Disease Sales Market Share in Value by Type (2024-2034)
Table 15. Global Eosinophilic Disease Price by Type (2024-2034) & (US$/Unit)
Table 16. North America Eosinophilic Disease Sales by Type (2024-2024) & (K Units)
Table 17. North America Eosinophilic Disease Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Eosinophilic Disease Sales (K Units) by Type (2024-2024)
Table 19. Europe Eosinophilic Disease Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Eosinophilic Disease Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific Eosinophilic Disease Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Eosinophilic Disease Sales (K Units) by Type (2024-2024)
Table 23. Latin America Eosinophilic Disease Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Eosinophilic Disease Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa Eosinophilic Disease Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Eosinophilic Disease Sales by Company (2024-2024) & (K Units)
Table 27. Global Eosinophilic Disease Sales Share by Company (2024-2024)
Table 28. Global Eosinophilic Disease Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Eosinophilic Disease Revenue Share by Company (2024-2024)
Table 30. Global Market Eosinophilic Disease Price by Company (2024-2024) & (US$/Unit)
Table 31. Global Eosinophilic Disease Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Eosinophilic Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eosinophilic Disease as of 2022)
Table 34. Date of Key Manufacturers Enter into Eosinophilic Disease Market
Table 35. Key Manufacturers Eosinophilic Disease Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Eosinophilic Disease Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Eosinophilic Disease Sales by Region (2024-2024) & (K Units)
Table 39. Global Eosinophilic Disease Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Eosinophilic Disease Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Eosinophilic Disease Sales Market Share in Value by Region (2024-2024)
Table 42. Global Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 43. Global Eosinophilic Disease Sales by Region (2024-2034) & (K Units)
Table 44. Global Eosinophilic Disease Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Eosinophilic Disease Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Eosinophilic Disease Sales Market Share in Value by Region (2024-2034)
Table 47. Global Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 48. Global Eosinophilic Disease Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Eosinophilic Disease Sales by Application (2024-2024) & (K Units)
Table 50. Global Eosinophilic Disease Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Eosinophilic Disease Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Eosinophilic Disease Sales Market Share in Value by Application (2024-2024)
Table 53. Global Eosinophilic Disease Price by Application (2024-2024) & (US$/Unit)
Table 54. Global Eosinophilic Disease Sales by Application (2024-2034) & (K Units)
Table 55. Global Eosinophilic Disease Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Eosinophilic Disease Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Eosinophilic Disease Sales Market Share in Value by Application (2024-2034)
Table 58. Global Eosinophilic Disease Price by Application (2024-2034) & (US$/Unit)
Table 59. North America Eosinophilic Disease Sales by Application (2024-2024) (K Units)
Table 60. North America Eosinophilic Disease Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Eosinophilic Disease Sales by Application (2024-2024) (K Units)
Table 62. Europe Eosinophilic Disease Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Eosinophilic Disease Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific Eosinophilic Disease Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Eosinophilic Disease Sales by Application (2024-2024) (K Units)
Table 66. Latin America Eosinophilic Disease Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Eosinophilic Disease Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa Eosinophilic Disease Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Eosinophilic Disease Sales by Country (2024-2024) & (K Units)
Table 70. North America Eosinophilic Disease Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Eosinophilic Disease Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Eosinophilic Disease Sales Market Share in Value by Country (2024-2024)
Table 73. North America Eosinophilic Disease Sales by Country (2024-2034) & (K Units)
Table 74. North America Eosinophilic Disease Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Eosinophilic Disease Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Eosinophilic Disease Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Eosinophilic Disease Sales by Country (2024-2024) & (K Units)
Table 78. Europe Eosinophilic Disease Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Eosinophilic Disease Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Eosinophilic Disease Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Eosinophilic Disease Sales by Country (2024-2034) & (K Units)
Table 82. Europe Eosinophilic Disease Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Eosinophilic Disease Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Eosinophilic Disease Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Eosinophilic Disease Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific Eosinophilic Disease Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Eosinophilic Disease Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Eosinophilic Disease Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Eosinophilic Disease Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Eosinophilic Disease Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Eosinophilic Disease Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Eosinophilic Disease Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Eosinophilic Disease Sales by Country (2024-2024) & (K Units)
Table 94. Latin America Eosinophilic Disease Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Eosinophilic Disease Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Eosinophilic Disease Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Eosinophilic Disease Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Eosinophilic Disease Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Eosinophilic Disease Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Eosinophilic Disease Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Eosinophilic Disease Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa Eosinophilic Disease Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Eosinophilic Disease Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Eosinophilic Disease Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Eosinophilic Disease Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Eosinophilic Disease Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Eosinophilic Disease Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Eosinophilic Disease Sales Market Share in Value by Country (2024-2034)
Table 109. Takeda Pharmaceutical Company Limited Company Information
Table 110. Takeda Pharmaceutical Company Limited Introduction and Business Overview
Table 111. Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 112. Takeda Pharmaceutical Company Limited Eosinophilic Disease Product
Table 113. Takeda Pharmaceutical Company Limited Recent Development
Table 114. Ellodi Pharmaceuticals Company Information
Table 115. Ellodi Pharmaceuticals Introduction and Business Overview
Table 116. Ellodi Pharmaceuticals Eosinophilic Disease Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 117. Ellodi Pharmaceuticals Eosinophilic Disease Product
Table 118. Ellodi Pharmaceuticals Recent Development
Table 119. Bristol-Myers Squibb Company Company Information
Table 120. Bristol-Myers Squibb Company Introduction and Business Overview
Table 121. Bristol-Myers Squibb Company Eosinophilic Disease Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 122. Bristol-Myers Squibb Company Eosinophilic Disease Product
Table 123. Bristol-Myers Squibb Company Recent Development
Table 124. AstraZeneca Company Information
Table 125. AstraZeneca Introduction and Business Overview
Table 126. AstraZeneca Eosinophilic Disease Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 127. AstraZeneca Eosinophilic Disease Product
Table 128. AstraZeneca Recent Development
Table 129. GSK plc Company Information
Table 130. GSK plc Introduction and Business Overview
Table 131. GSK plc Eosinophilic Disease Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 132. GSK plc Eosinophilic Disease Product
Table 133. GSK plc Recent Development
Table 134. Regeneron Pharmaceuticals Inc Company Information
Table 135. Regeneron Pharmaceuticals Inc Introduction and Business Overview
Table 136. Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 137. Regeneron Pharmaceuticals Inc Eosinophilic Disease Product
Table 138. Regeneron Pharmaceuticals Inc Recent Development
Table 139. Allakos Inc Company Information
Table 140. Allakos Inc Introduction and Business Overview
Table 141. Allakos Inc Eosinophilic Disease Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 142. Allakos Inc Eosinophilic Disease Product
Table 143. Allakos Inc Recent Development
Table 144. Arena Pharmaceuticals Ltd Company Information
Table 145. Arena Pharmaceuticals Ltd Introduction and Business Overview
Table 146. Arena Pharmaceuticals Ltd Eosinophilic Disease Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 147. Arena Pharmaceuticals Ltd Eosinophilic Disease Product
Table 148. Arena Pharmaceuticals Ltd Recent Development
Table 149. Revolo Biotherapeutics Company Information
Table 150. Revolo Biotherapeutics Introduction and Business Overview
Table 151. Revolo Biotherapeutics Eosinophilic Disease Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 152. Revolo Biotherapeutics Eosinophilic Disease Product
Table 153. Revolo Biotherapeutics Recent Development
Table 154. DBV Technologies Company Information
Table 155. DBV Technologies Introduction and Business Overview
Table 156. DBV Technologies Eosinophilic Disease Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 157. DBV Technologies Eosinophilic Disease Product
Table 158. DBV Technologies Recent Development
Table 159. Cipla Inc Company Information
Table 160. Cipla Inc Introduction and Business Overview
Table 161. Cipla Inc Eosinophilic Disease Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 162. Cipla Inc Eosinophilic Disease Product
Table 163. Cipla Inc Recent Development
Table 164. Sun Pharmaceutical Industries Ltd Company Information
Table 165. Sun Pharmaceutical Industries Ltd Introduction and Business Overview
Table 166. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 167. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Product
Table 168. Sun Pharmaceutical Industries Ltd Recent Development
Table 169. Sanofi Company Information
Table 170. Sanofi Introduction and Business Overview
Table 171. Sanofi Eosinophilic Disease Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 172. Sanofi Eosinophilic Disease Product
Table 173. Sanofi Recent Development
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. Eosinophilic Disease Market Trends
Table 177. Eosinophilic Disease Market Drivers
Table 178. Eosinophilic Disease Market Challenges
Table 179. Eosinophilic Disease Market Restraints
Table 180. Eosinophilic Disease Distributors List
Table 181. Eosinophilic Disease Downstream Customers
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Eosinophilic Disease Product Picture
Figure 2. Global Eosinophilic Disease Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Eosinophilic Disease Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Eosinophilic Disease Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Corticosteroids
Figure 6. Global Corticosteroids Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Monoclonal Antibodies
Figure 8. Global Monoclonal Antibodies Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Anti-cytokine Drug
Figure 10. Global Anti-cytokine Drug Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Cytotoxic Drug
Figure 12. Global Cytotoxic Drug Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global Eosinophilic Disease Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Eosinophilic Disease Sales Market Share by Type in 2022 & 2034
Figure 15. North America Eosinophilic Disease Sales Market Share in Volume by Type in 2022
Figure 16. North America Eosinophilic Disease Sales Market Share in Value by Type in 2022
Figure 17. Europe Eosinophilic Disease Sales Market Share in Volume by Type in 2022
Figure 18. Europe Eosinophilic Disease Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Eosinophilic Disease Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Eosinophilic Disease Sales Market Share in Value by Type in 2022
Figure 21. Latin America Eosinophilic Disease Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Eosinophilic Disease Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Eosinophilic Disease Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Eosinophilic Disease Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Eosinophilic Disease Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Eosinophilic Disease Revenue in 2022
Figure 27. Eosinophilic Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Eosinophilic Esophagitis
Figure 29. Global Eosinophilic Esophagitis Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Eosinophilic Granulomatosis with Polyangiitis
Figure 31. Global Eosinophilic Granulomatosis with Polyangiitis Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Hyper-eosinophilic Syndrome
Figure 33. Global Hyper-eosinophilic Syndrome Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Nasal Polyposis
Figure 35. Global Nasal Polyposis Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of Other
Figure 37. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Global Eosinophilic Disease Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global Eosinophilic Disease Sales Market Share by Application in 2022 & 2034
Figure 40. North America Eosinophilic Disease Sales Market Share in Volume by Application in 2022
Figure 41. North America Eosinophilic Disease Sales Market Share in Value by Application in 2022
Figure 42. Europe Eosinophilic Disease Sales Market Share in Volume by Application in 2022
Figure 43. Europe Eosinophilic Disease Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Eosinophilic Disease Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Eosinophilic Disease Sales Market Share in Value by Application in 2022
Figure 46. Latin America Eosinophilic Disease Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Eosinophilic Disease Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Eosinophilic Disease Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Eosinophilic Disease Manufacturing Cost Structure
Figure 51. Eosinophilic Disease Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries